Cite
HARVARD Citation
Su, Y. et al. (2015). Adding Bevacizumab to Chemotherapy Effectively Control Radioresistant Brain Metastases in ALK-Positive Lung Adenocarcinoma. Journal of thoracic oncology. 10 (4), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Su, Y. et al. (2015). Adding Bevacizumab to Chemotherapy Effectively Control Radioresistant Brain Metastases in ALK-Positive Lung Adenocarcinoma. Journal of thoracic oncology. 10 (4), p. . [Online].